An MIT study found that over half of FDA-approved drugs since 2000 have connections to NIH research, highlighting the ...
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid ...
News-Medical.Net on MSN
Analysis shows potential impact of deep NIH budget cuts on future drug development
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid ...
Leukemia and lymphoma are cancers that affect the blood or bone marrow. Fifteen percent of people with leukemia have chronic myeloid leukemia (CML), which has seen a 55% jump in new cases over the ...
Leukemia is a blood cancer that disrupts normal cell production, leading to infection risk, anemia and bleeding, and requiring tailored treatments.
The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...
Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients. In your work with caregivers, how have you seen them ...
Blood cancer made a Rickmansworth woman “feel like a fraud”, but she has highlighted the unseen impact. Kate Smith has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results